ASH: GLP-1 RA Use Tied to Lower Rate of Venous Thromboembolism in Diabetes
Significant reduction seen in VTE rates, with similar reductions for patients with and without obesity
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.